Association of Genetic Variants Related to Serum Calcium Levels with Reduced Bone Mineral Density.
The role of serum calcium in bone metabolism is unknown, although calcium/vitamin D supplementations have been widely used, expected to improve bone health.We aim to determine the independent role of serum calcium in bone mineral density (BMD). Two epidemiological analyses with 5,478 and 5,556 participants from the National Health and Nutrition Examination Survey (NHANES) 2003-6 and the Hong Kong Osteoporosis Study (HKOS) to evaluate cross-sectional association of serum calcium with BMD. Two-sample mendelian randomization (MR) study using genetic variations as instrumental variables to infer causality. Summary statistics of genome-wide association study of serum calcium (N=39,400) and life-long whole-body BMD (N=66,628) were used. BMD measured by dual-energy X-ray absorptiometry. In NHANES 2003-6 and HKOS, each SD increase in serum calcium was significantly associated with 0.036-0.092 SD decrease in BMD at various sites (all P<0.05). In multivariable inverse-variance weighted MR analysis, genetic predisposition to higher serum calcium level was inversely associated with whole-body BMD after adjustment for serum parathyroid hormone, vitamin D, and phosphate (-0.431 SD per SD increase in serum calcium; 95% CI: -0.773 to -0.089, P=0.014). Similar estimates were obtained in sensitivity analyses. Our study reveals that genetic predisposition to higher serum calcium level per se may have negative impact on bone metabolism. Whether increased serum calcium caused by calcium/vitamin D supplementations would have the same negative effect on bone remains unknown, which warrants further investigation. In addition to other adverse clinical outcomes, careful use of high-dose supplementations is required.